Chatsworth-based cancer diagnostics and treatment product company North American Scientific Inc. received Food and Drug Administration approval to market a radiation design of the breast cancer treatment it development. ClearPath uses radioactive seeds placed in the breast using needles, catheters or other devices. The FDA approved the internal radiation, called breast brachytherapy, and the specific design of ClearPath. North American Scientific received approval to market the low-dose version in April.